Anrui Biomedical Technology (Guangzhou) Co., Ltd.

Chine

 
Quantité totale PI 11
Rang # Quantité totale PI 139 430
Note d'activité PI 2,1/5.0    17
Rang # Activité PI 49 511

Brevets

Marques

2 0
1 0
8 0
0
 
Dernier brevet 2024 - Imidazolopyridazine or pyrazolop...
Premier brevet 2021 - Amino heteroaryl compounds and c...

Derniers inventions, produits et services

2023 Invention Phosphoramidate compounds and uses thereof. Provided herein are novel compounds (e.g., Formula I,...
Invention Aminoheteroaryl kinase inhibitors. Provided herein are novel compounds (e.g., Formula I or II), p...
Invention Covalent binding compounds and compositions. Provided herein are novel compounds (e.g., Formula I...
2022 Invention Aminoheteroaryl kinase inhibitors. Provided herein are novel compounds, pharmaceutical compositio...
Invention Imidazolopyridazine or pyrazolopyrimidine compounds and compositions. Provided herein are novel ...
Invention Imidazolopyridazine or pyrazolopyrimidine compounds and compositions. Provided herein are novel c...
2021 Invention Disubstituted cyclopentane kinase inhibitors. Provided herein are novel compounds (e.g., Formula ...
Invention Amino heteroaryl compounds and compositions. Provided herein are novel compounds (e.g., Formula ...
Invention Amino heteroaryl compounds and compositions. Provided herein are novel compounds (e.g., Formula I...